KRAS and non-small cell lung carcinoma: However, in our recent in vivo study, we demonstrated a gender-specific correlation between STAT3 expression and KRAS-mutant NSCLC; female mice with tumor-cell-specific STAT3 deletion showed decreased tumorigenesis while males had the opposite outcome [121].